X
Tricog
Connect: •••
•••• ••••
•••
Key Metrics of Tricog
  • Market Cap
  • Total Equity Funding ₹231 Cr in 8 rounds
  • Latest Funding Round ₹70 Cr, Series B Apr 20, 2023
  • Post Money Valuation ₹40 Cr as on Oct 03, 2016
  • Annual Revenue ₹78 Cr
    ▲ 25% YoYas on Mar 31, 2025
  • EBITDA ₹3.2 Cr
    ▲ 3% YoYas on Mar 31, 2025
  • EBITDA Margin 4.06%
    ▼ 18% YoYas on Mar 31, 2025
  • Net Profit ₹1.3 Cr (Loss)
    ▼ 277% YoYas on Mar 31, 2025
  • Net Profit Margin -1.63%
    ▼ 242% YoYas on Mar 31, 2025
About the Company

Provider of AI-enabled platform for remote cardiac diagnosis and management. The platform offers solutions for clinics, hospitals, diagnostics centers, and...

Loading...
Price on BSE Volume

Funding Rounds

Total Rounds: 8 Tricog

S.No. Date Round Name Amount TTM Revenue Investors & Facilitators
1. Apr 20, 2023 Series B ₹70 Cr ₹49 Cr
Inst: Omron, Sony Innovation Fund, SGInnovate, UTEC, Athera
2. Feb 28, 2023 Series B ₹41 Cr ₹46 Cr
Inst: Sony Innovation Fund, SGInnovate, UTEC
3. Mar 3, 2020 Series B ₹77 Cr ₹17 Cr
Inst: UTEC, TEAMFund, Blume Venture, Aflac Ventures, Athera, Inventus Capital Partners, Dream Incubator
4. Sep 2018 Series A - -
Inst: SGInnovate
5. Feb 21, 2018 Series A ₹26 Cr -
Inst: UTEC
6. Jul 18, 2016 Series A ₹13 Cr -
Inst: Blume Venture, Athera
Facil: Draper Venture Network, Aurum Equity Partners
7. May 25, 2016 Seed ₹1.5 Cr -
Inst: Amnyk, Equipments and Spares, Shivam Associates
Angel: Beena Ankit, S S, S R
8. Jan 24, 2015 Seed ₹2.7 Cr -
Inst: Amnyk, Bangalore Software Services, Equipments and Spares, Shivam Associates
Angel: Avinash, B Ramana, Beena Ankit, Alok, Deepti, Shardendu, Amit, S S, S R

Financial Statements

Revenue - INR (Cr)

Net Profit/Loss - INR (Cr)

Select a year from the tabs

FY 24-25
FY 23-24
FY 22-23
FY 21-22
FY 20-21
FY 19-20
FY 18-19
FY 17-18
Detailed Income StatementFY 24-25 (in Cr)
77.7
79.4
Total profit before prior period items, exceptional items, extraordinary items and tax (1.7)
Exceptional items before tax 0
Total profit before extraordinary items and tax (1.7)
Extraordinary items before tax 0
Total profit before tax (1.7)
(0.4)
Total profit (loss) for period from continuing operations (1.3)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period (1.3)
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items (0.0)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 24-25 (in Cr)
53.4
53.4
Detailed Cash Flow StatementFY 24-25 (in Cr)
Detailed Income StatementFY 23-24 (in Cr)
62.3
61.8
Total profit before prior period items, exceptional items, extraordinary items and tax 0.6
Exceptional items before tax 0
Total profit before extraordinary items and tax 0.6
Extraordinary items before tax 0
Total profit before tax 0.6
(0.1)
Total profit (loss) for period from continuing operations 0.7
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period 0.7
Basic earning per equity share before extraordinary items 0.0
Diluted earnings per equity share before extraordinary items 0.0
Basic earning per equity share 0.0
Diluted earnings per equity share 0.0
Detailed Balance SheetFY 23-24 (in Cr)
27.7
27.7
Detailed Cash Flow StatementFY 23-24 (in Cr)
Detailed Income StatementFY 22-23 (in Cr)
47.2
59.9
Total profit before prior period items, exceptional items, extraordinary items and tax (12.6)
Exceptional items before tax 0
Total profit before extraordinary items and tax (12.6)
Extraordinary items before tax 0
Total profit before tax (12.6)
(0.3)
Total profit (loss) for period from continuing operations (12.3)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period (12.3)
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items 0
Basic earning per equity share (0.0)
Diluted earnings per equity share 0
Detailed Balance SheetFY 22-23 (in Cr)
23.0
23.0
Detailed Cash Flow StatementFY 22-23 (in Cr)
Detailed Income StatementFY 21-22 (in Cr)
32.7
38.6
Total profit before prior period items, exceptional items, extraordinary items and tax (5.9)
Exceptional items before tax 0
Total profit before extraordinary items and tax (5.9)
Extraordinary items before tax 0
Total profit before tax (5.9)
(0.4)
Total profit (loss) for period from continuing operations (5.6)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period (5.6)
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items (0.0)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 21-22 (in Cr)
18.5
18.5
Detailed Cash Flow StatementFY 21-22 (in Cr)
Detailed Income StatementFY 20-21 (in Cr)
19.6
31.4
Total profit before prior period items, exceptional items, extraordinary items and tax (11.8)
Exceptional items before tax 0
Total profit before extraordinary items and tax (11.8)
Extraordinary items before tax 0
Total profit before tax (11.8)
(0.1)
Total profit (loss) for period from continuing operations (11.6)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period (11.6)
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items (0.0)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 20-21 (in Cr)
13.5
13.5
Detailed Cash Flow StatementFY 20-21 (in Cr)
Detailed Income StatementFY 19-20 (in Cr)
17.0
20.9
Total profit before prior period items, exceptional items, extraordinary items and tax (3.9)
Exceptional items before tax 0
Total profit before extraordinary items and tax (3.9)
Extraordinary items before tax 0
Total profit before tax (3.9)
(0.1)
Total profit (loss) for period from continuing operations (3.8)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period (3.8)
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items (0.0)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 19-20 (in Cr)
8.1
8.1
Detailed Cash Flow StatementFY 19-20 (in Cr)
Detailed Income StatementFY 18-19 (in Cr)
0
0.0
Total profit before prior period items, exceptional items, extraordinary items and tax (0.0)
Exceptional items before tax 0
Total profit before extraordinary items and tax (0.0)
Extraordinary items before tax 0
Total profit before tax (0.0)
0.0
Total profit (loss) for period from continuing operations (0.0)
Profit (loss) from discontinuing operations before tax 0
Tax expense of discontinuing operations 0
Total profit (loss) from discontinuing operation after tax 0
Total profit (loss) for period (0.0)
Basic earning per equity share before extraordinary items (0.0)
Diluted earnings per equity share before extraordinary items (0.0)
Basic earning per equity share (0.0)
Diluted earnings per equity share (0.0)
Detailed Balance SheetFY 18-19 (in Cr)
1.0
1.0
Detailed Cash Flow StatementFY 18-19 (in Cr)
Detailed Income StatementFY 17-18 (in Cr)
Detailed Balance SheetFY 17-18 (in Cr)
0.0
0.0
Detailed Cash Flow StatementFY 17-18 (in Cr)

Shareholding Pattern

As of Mar 31, 2024 • Tricog

Total Shares 0.07M

Top Shareholders

Shareholder Category Shares (Mn) % Holding
Charit Bhograj Founder 0.01M 19.42%
Zainul Charbiwala Founder 0.01M 19.42%
Inventus Capital Partner Fund II Ltd Fund 0.01M 18.68%
Blume Ventures Fund II Fund 0.01M 8.33%
ESOP Pool Available ESOP Pool 0.01M 7.62%
Others

    Top Competitors

    Similar companies to Tricog

    Ultromics

    ultromics.com

    PLUX

    pluxbiosignals.com

    Fifth Eye

    fiftheye.com

    CardioLogs

    cardiologs.com

    Cardioline

    cardioline.com

    Kubios

    kubios.com

    Latest News

    Updates on Tricog
    Need help? Chat with us! WhatsApp